APVO210
8001
Phase 1 mab terminated
Quick answer
APVO210 for Psoriasis is a Phase 1 program (mab) at Aptevo Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aptevo Therapeutics
- Indication
- Psoriasis
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated